Biocryst Pharmaceuticals logo

Biocryst Pharmaceuticals Share Price Today

(NASDAQ: BCRX)

Biocryst Pharmaceuticals share price is $8.05 & ₹700.10 as on 6 Mar 2025, 2.30 'hrs' IST

$8.05

-0.26

(-3.13%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Biocryst Pharmaceuticals share price in Dollar and Rupees. Guide to invest in Biocryst Pharmaceuticals stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Biocryst Pharmaceuticals, along with analyst recommendations, forecasts, and comprehensive financials.

Biocryst Pharmaceuticals share price movements

  • Today's Low: $7.91
    Today's High: $8.36

    Day's Volatility :5.39%

  • 52 Weeks Low: $4.03
    52 Weeks High: $9.50

    52 Weeks Volatility :57.58%

Biocryst Pharmaceuticals (BCRX) Returns

PeriodBiocryst Pharmaceuticals IncSector (Health Care)Index (Russel 2000)
3 Months
5.99%
2.1%
0.0%
6 Months
2.21%
-4.1%
0.0%
1 Year
59.5%
2.2%
0.0%
3 Years
-52.13%
11.8%
-11.6%

Biocryst Pharmaceuticals (BCRX) Key Statistics

in dollars & INR

Previous Close
$8.31
Open
$8.3
Today's High
$8.355
Today's Low
$7.905
Market Capitalization
$1.8B
Today's Volume
$1.1M
52 Week High
$9.5
52 Week Low
$4.03
Revenue TTM
$450.7M
EBITDA
$1.7M
Earnings Per Share (EPS)
$-0.43
Profit Margin
-19.72%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-1925.37%

How to invest in Biocryst Pharmaceuticals Stock (BCRX) from India?

It is very easy for Indian residents to invest directly in Biocryst Pharmaceuticals from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Biocryst Pharmaceuticals stock in both Indian Rupees (INR) and US Dollars (USD). Search for Biocryst Pharmaceuticals or BCRX on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Biocryst Pharmaceuticals or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Biocryst Pharmaceuticals shares which would translate to 0.108 fractional shares of Biocryst Pharmaceuticals as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Biocryst Pharmaceuticals, in just a few clicks!

Returns in Biocryst Pharmaceuticals (BCRX) for Indian investors in Rupees

The Biocryst Pharmaceuticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Biocryst Pharmaceuticals investment value today

Current value as on today

₹1,59,473

Returns

₹59,473

(+59.47%)

Returns from Biocryst Pharmaceuticals Stock

₹54,511 (+54.51%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Biocryst Pharmaceuticals (BCRX)

1200.0%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Investment in Biocryst Pharmaceuticals Shares from India has grown by 1200.0% over the past 30 days, indicating increased transactional activity.

381%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Biocryst Pharmaceuticals Stock from India on INDmoney has increased by 381% in the last 30 days, reflecting an upward trend in search activity.

Global Institutional Holdings in Biocryst Pharmaceuticals

  • BlackRock Inc

    10.57%

  • Vanguard Group Inc

    10.48%

  • venBio Select Advisor LLC

    5.68%

  • Kynam Capital Management, LP

    4.35%

  • Deerfield Management Co

    3.90%

  • State Street Corp

    3.59%

Analyst Recommendation on Biocryst Pharmaceuticals

Buy

    83%Buy

    16%Hold

    0%Sell

Based on 18 Wall street analysts offering stock ratings for Biocryst Pharmaceuticals(by analysts ranked 0 to 5 stars)

Based on 18 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
15
15
15
Hold
3
3
3
Sell
0
0
0

Analyst Forecast on Biocryst Pharmaceuticals Stock (BCRX)

What analysts predicted

Upside of 91.51%

Target:

$15.42

Current:

$8.05

Insights on Biocryst Pharmaceuticals Stock (Ticker Symbol: BCRX)

  • Price Movement

    In the last 1 year, BCRX stock has moved up by 53.6%
  • Increasing Revenue

    Revenue is up for the last 4 quarters, 92.76M → 131.53M (in $), with an average increase of 10.9% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, -12.67M → -26.79M (in $), with an average decrease of 50.8% per quarter
  • BCRX vs ITCI (1 yr)

    In the last 1 year, Intra-cellular Therapies, Inc. has given 97.0% return, outperforming this stock by 43.4%
  • BCRX vs ITCI (3 yr)

    In the last 3 years, Intra-cellular Therapies, Inc. has given 138.2% return, outperforming this stock by 186.6%
  • Price to Sales

    ForBCRX every $1 of sales, investors are willing to pay $3.8, whereas for Intra-cellular Therapies, Inc., the investors are paying $19.9 for every $1 of sales.

Biocryst Pharmaceuticals Technicals Summary

Sell

Neutral

Buy

Biocryst Pharmaceuticals is currently in a neutral trading position according to technical analysis indicators.

Biocryst Pharmaceuticals (BCRX) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Biocryst Pharmaceuticals Inc logo
9.06%
2.21%
59.5%
-52.13%
163.81%
Intra-cellular Therapies, Inc. logo
3.42%
81.22%
98.76%
146.55%
588.92%
Haleon Plc Spon Ads logo
12.55%
3.39%
28.09%
43.99%
43.99%
Zoetis Inc. logo
-1.19%
-8.94%
-7.43%
-9.67%
30.97%
Neurocrine Biosciences Inc. logo
-24.64%
-6.68%
-14.47%
28.61%
27.88%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Biocryst Pharmaceuticals Inc logo
NA
NA
-0.28
-0.07
-19.25
0.0
NA
-2.28
Intra-cellular Therapies, Inc. logo
NA
NA
0.0
0.13
-0.09
-0.07
NA
10.81
Haleon Plc Spon Ads logo
26.68
26.68
1.5
0.36
0.09
0.04
0.02
1.8
Zoetis Inc. logo
31.17
31.17
3.01
6.07
0.51
0.15
0.01
10.64
Neurocrine Biosciences Inc. logo
34.8
34.8
0.27
6.47
0.14
0.1
NA
26.05
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Biocryst Pharmaceuticals Inc logo
Buy
$1.8B
163.81%
NA
-19.72%
Intra-cellular Therapies, Inc. logo
Buy
$14.0B
588.92%
NA
-10.97%
Haleon Plc Spon Ads logo
Buy
$48.2B
43.99%
26.68
12.84%
Zoetis Inc. logo
Buy
$76.1B
30.97%
31.17
26.86%
Neurocrine Biosciences Inc. logo
Buy
$11.3B
27.88%
34.8
14.49%

About Biocryst Pharmaceuticals

BioCryst Pharmaceuticals, Inc., a biotechnology company, develops oral small-molecule and injectable protein therapeutics to treat rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX17725, a protein therapeutic for netherton syndrome which is in phase 1; Avoralstat, an ocular plasma kallikrein inhibitor for diabetic macular edema that is in preclinical phase; and BCX10013, an oral Factor D inhibitor for complement-mediated diseases, as well as developing Oral C5 Inhibitor and Oral C2 Inhibitor. The company has collaborations and in-license relationships with the Torii Pharmaceutical Co., Shionogi & Co., Ltd., Green Cross Corporation; National Institute of Allergy and Infectious Diseases; Biomedical Advanced Research and Development Authority; the U.S. Department of Health and Human Services; and The University of Alabama at Birmingham, as well as Albert Einstein College of Medicine of Yeshiva University and Industrial Research, Ltd. BioCryst Pharmaceuticals, Inc. was founded in 1986 and is headquartered in Durham, North Carolina.
Organization
Biocryst Pharmaceuticals
Employees
580
CEO
Mr. Jon P. Stonehouse
Industry
Health Technology

Management People of Biocryst Pharmaceuticals

NameTitle
Mr. Jon P. Stonehouse
CEO, President & Executive Director
Mr. Anthony J. Doyle
Senior VP, CFO & Interim Principal Accounting Officer
Ms. Alane P. Barnes
Senior VP, Chief Legal Officer & Corporate Secretary
Dr. Helen M. Thackray FAAP, M.D.
Chief Research & Development Officer
Mr. Charles K. Gayer
Senior VP & Chief Commercial Officer
Mr. John D. Bluth
Chief Communications Officer
Ms. Stephanie Angelini
Chief People Officer
Dr. William P. Sheridan MBBS
Chief Development Officer
Dr. Yarlagadda S. Babu Ph.D.
Chief Discovery Officer
Ms. Jinky Ang Rosselli
Chief Data & Insights Officer

Important FAQs about investing in BCRX Stock from India :

What is Biocryst Pharmaceuticals share price today?

Biocryst Pharmaceuticals share price today stands at $8.05, Open: $8.30 ; Previous Close: $8.31 ; High: $8.36 ; Low: $7.91 ; 52 Week High: $9.50 ; 52 Week Low: $4.03.

The stock opens at $8.30, after a previous close of $8.31. The stock reached a daily high of $8.36 and a low of $7.91, with a 52-week high of $9.50 and a 52-week low of $4.03.

Can Indians buy Biocryst Pharmaceuticals shares?

Yes, Indians can invest in the Biocryst Pharmaceuticals (BCRX) from India.

With INDmoney, you can buy Biocryst Pharmaceuticals at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Biocryst Pharmaceuticals at zero transaction cost.

How can I buy Biocryst Pharmaceuticals shares from India?

It is very easy to buy Biocryst Pharmaceuticals from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Biocryst Pharmaceuticals (BCRX) be purchased?

Yes, you can buy fractional shares of Biocryst Pharmaceuticals with INDmoney app.

What are the documents required to start investing in Biocryst Pharmaceuticals stocks?

To start investing in Biocryst Pharmaceuticals, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Biocryst Pharmaceuticals Stock (BCRX)?

Today’s highest price of Biocryst Pharmaceuticals (BCRX) is $8.36.

Today’s lowest price of Biocryst Pharmaceuticals (BCRX) is $7.91.

What is today's market capitalisation of Biocryst Pharmaceuticals?

Today's market capitalisation of Biocryst Pharmaceuticals BCRX is 1.8B

What is the 52 Week High and Low Range of Biocryst Pharmaceuticals Stock (BCRX)?

  • 52 Week High

    $9.50

  • 52 Week Low

    $4.03

What are the historical returns of Biocryst Pharmaceuticals (BCRX)?

  • 1 Month Returns

    9.06%

  • 3 Months Returns

    2.21%

  • 1 Year Returns

    59.5%

  • 5 Years Returns

    163.81%

Who is the Chief Executive Officer (CEO) of Biocryst Pharmaceuticals ?

Mr. Jon P. Stonehouse is the current Chief Executive Officer (CEO) of Biocryst Pharmaceuticals.